Current State and Perspectives of Dendritic Cell Vaccination in Cancer Immunotherapy

Publisher： Karger

E-ISSN： 1660-5535|19|3|124-131

ISSN： 1660-5527

Source： Skin Pharmacology and Physiology, Vol.19, Iss.3, 2006-06, pp. : 124-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation

By Sittig Simone P. de Vries I. Jolanda M. Schreibelt Gerty

Biomedicines, Vol. 3, Iss. 4, 2015-12 ,pp. : 282-303

MDPI

Access to resources Recommend Favorite

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives

By Kitamura Hiroshi Tsukamoto Taiji

Cancers, Vol. 3, Iss. 3, 2011-07 ,pp. : 3055-3072

MDPI

Access to resources Recommend Favorite

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

By Koido Shigeo

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-05 ,pp. : 828-828

MDPI

Access to resources Recommend Favorite

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer

By Tuohy Vincent K. Jaini Ritika Johnson Justin M. Loya Matthew G. Wilk Dennis Downs-Kelly Erinn Mazumder Suparna

Cancers, Vol. 8, Iss. 6, 2016-06 ,pp. : 56-56

MDPI

Access to resources Recommend Favorite

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners

By Cappello Paola Curcio Claudia Mandili Giorgia Roux Cecilia Bulfamante Sara Novelli Francesco

Cancers, Vol. 10, Iss. 2, 2018-02 ,pp. : 51-51

MDPI

Access to resources Recommend Favorite